Shandong Lukang Pharmaceutical to host 2025 half-year performance briefing

Shandong Lukang Pharmaceutical Co., Ltd. will host a 2025 half-year performance briefing on Friday, September 19, 2025, from 15:00 to 16:00. The briefing will be conducted online via the All-Panorama Network's "Investor Relations Interaction Platform" (http://ir.p5w.net), following the release of the company's 2025 half-year report on August 28, 2025. This event aims to provide investors with a comprehensive understanding of the company's operating results and financial condition for the first half of the year.

Key participants in the briefing will include chairman Peng Xin, chief financial officer Zhang Jing, independent directors Deng Zixin, Qi Haodong, and Feng Liling, and board secretary Jing Baokun. The company encourages investors to submit questions in advance via email to lkpc_dmc@126.com by September 19, 2025. During the online interactive session, the company will address questions and engage in discussions regarding its operational achievements and financial metrics within the scope of information disclosure.

For any inquiries, investors can contact the company's securities department at 0537-2983174 or via email at lkpc_dmc@126.com. Following the briefing, a record of the event and its key contents will be available on the All-Panorama Network's "Investor Relations Interaction Platform."